Global G-CSF Injection Market Research Report 2025(Status and Outlook)
Description
Report Overview
The market for G-CSF (Granulocyte Colony-Stimulating Factor) injections is driven by their critical role in stimulating white blood cell production, particularly in cancer patients undergoing chemotherapy, which often suppresses bone marrow function. These injections are also used in treating neutropenia, stem cell transplantation, and chronic autoimmune conditions. The increasing prevalence of cancer, advancements in biologics, and rising demand for supportive care therapies contribute to steady market growth. Biosimilars are gaining traction due to cost pressures in healthcare systems, though branded products still hold significant market share. Regulatory approvals, reimbursement policies, and expanding applications in emerging markets further shape the competitive landscape. Key players focus on innovation, strategic partnerships, and geographic expansion to capitalize on growing demand. Challenges include high treatment costs, stringent regulatory requirements, and potential side effects, but the market remains robust with a projected upward trajectory.
The global G-CSF Injection market size was estimated at USD 3156.53 million in 2024, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global G-CSF Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global G-CSF Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the G-CSF Injection market in any manner.
Global G-CSF Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc.
Pfizer
Sandoz (Novartis)
Spectrum Pharmaceuticals
Biocon Biologics Inc.
Coherus BioSciences
Inc.
Teva Pharmaceutical
Sanofi
Yifan Pharmaceutical
CSPC
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Shan Dong Kexing Biopharm
Market Segmentation (by Type)
Long-acting G-CSF Injection
Short-acting G-CSF Injection
Market Segmentation (by Application)
Neoplastic Diseases
Blood Disorders
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the G-CSF Injection Market
Overview of the regional outlook of the G-CSF Injection Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the G-CSF Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of G-CSF Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The market for G-CSF (Granulocyte Colony-Stimulating Factor) injections is driven by their critical role in stimulating white blood cell production, particularly in cancer patients undergoing chemotherapy, which often suppresses bone marrow function. These injections are also used in treating neutropenia, stem cell transplantation, and chronic autoimmune conditions. The increasing prevalence of cancer, advancements in biologics, and rising demand for supportive care therapies contribute to steady market growth. Biosimilars are gaining traction due to cost pressures in healthcare systems, though branded products still hold significant market share. Regulatory approvals, reimbursement policies, and expanding applications in emerging markets further shape the competitive landscape. Key players focus on innovation, strategic partnerships, and geographic expansion to capitalize on growing demand. Challenges include high treatment costs, stringent regulatory requirements, and potential side effects, but the market remains robust with a projected upward trajectory.
The global G-CSF Injection market size was estimated at USD 3156.53 million in 2024, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global G-CSF Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global G-CSF Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the G-CSF Injection market in any manner.
Global G-CSF Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc.
Pfizer
Sandoz (Novartis)
Spectrum Pharmaceuticals
Biocon Biologics Inc.
Coherus BioSciences
Inc.
Teva Pharmaceutical
Sanofi
Yifan Pharmaceutical
CSPC
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Shan Dong Kexing Biopharm
Market Segmentation (by Type)
Long-acting G-CSF Injection
Short-acting G-CSF Injection
Market Segmentation (by Application)
Neoplastic Diseases
Blood Disorders
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the G-CSF Injection Market
Overview of the regional outlook of the G-CSF Injection Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the G-CSF Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of G-CSF Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
113 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of G-CSF Injection
- 1.2 Key Market Segments
- 1.2.1 G-CSF Injection Segment by Type
- 1.2.2 G-CSF Injection Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 G-CSF Injection Market Overview
- 2.1 Global Market Overview
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 G-CSF Injection Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global G-CSF Injection Product Life Cycle
- 3.3 Global G-CSF Injection Revenue Market Share by Company (2020-2025)
- 3.4 G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.5 G-CSF Injection Company Headquarters, Area Served, Product Type
- 3.6 G-CSF Injection Market Competitive Situation and Trends
- 3.6.1 G-CSF Injection Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest G-CSF Injection Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 G-CSF Injection Value Chain Analysis
- 4.1 G-CSF Injection Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development and Dynamics of G-CSF Injection Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global G-CSF Injection Market Porter's Five Forces Analysis
- 6 G-CSF Injection Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global G-CSF Injection Market Size Market Share by Type (2020-2025)
- 6.3 Global G-CSF Injection Market Size Growth Rate by Type (2021-2025)
- 7 G-CSF Injection Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global G-CSF Injection Market Size (M USD) by Application (2020-2025)
- 7.3 Global G-CSF Injection Sales Growth Rate by Application (2020-2025)
- 8 G-CSF Injection Market Segmentation by Region
- 8.1 Global G-CSF Injection Market Size by Region
- 8.1.1 Global G-CSF Injection Market Size by Region
- 8.1.2 Global G-CSF Injection Market Size Market Share by Region
- 8.2 North America
- 8.2.1 North America G-CSF Injection Market Size by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe G-CSF Injection Market Size by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Spain
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific G-CSF Injection Market Size by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America G-CSF Injection Market Size by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa G-CSF Injection Market Size by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Amgen Inc.
- 9.1.1 Amgen Inc. Basic Information
- 9.1.2 Amgen Inc. G-CSF Injection Product Overview
- 9.1.3 Amgen Inc. G-CSF Injection Product Market Performance
- 9.1.4 Amgen Inc. SWOT Analysis
- 9.1.5 Amgen Inc. Business Overview
- 9.1.6 Amgen Inc. Recent Developments
- 9.2 Pfizer
- 9.2.1 Pfizer Basic Information
- 9.2.2 Pfizer G-CSF Injection Product Overview
- 9.2.3 Pfizer G-CSF Injection Product Market Performance
- 9.2.4 Pfizer SWOT Analysis
- 9.2.5 Pfizer Business Overview
- 9.2.6 Pfizer Recent Developments
- 9.3 Sandoz (Novartis)
- 9.3.1 Sandoz (Novartis) Basic Information
- 9.3.2 Sandoz (Novartis) G-CSF Injection Product Overview
- 9.3.3 Sandoz (Novartis) G-CSF Injection Product Market Performance
- 9.3.4 Sandoz (Novartis) SWOT Analysis
- 9.3.5 Sandoz (Novartis) Business Overview
- 9.3.6 Sandoz (Novartis) Recent Developments
- 9.4 Spectrum Pharmaceuticals
- 9.4.1 Spectrum Pharmaceuticals Basic Information
- 9.4.2 Spectrum Pharmaceuticals G-CSF Injection Product Overview
- 9.4.3 Spectrum Pharmaceuticals G-CSF Injection Product Market Performance
- 9.4.4 Spectrum Pharmaceuticals Business Overview
- 9.4.5 Spectrum Pharmaceuticals Recent Developments
- 9.5 Biocon Biologics Inc.
- 9.5.1 Biocon Biologics Inc. Basic Information
- 9.5.2 Biocon Biologics Inc. G-CSF Injection Product Overview
- 9.5.3 Biocon Biologics Inc. G-CSF Injection Product Market Performance
- 9.5.4 Biocon Biologics Inc. Business Overview
- 9.5.5 Biocon Biologics Inc. Recent Developments
- 9.6 Coherus BioSciences
- 9.6.1 Coherus BioSciences Basic Information
- 9.6.2 Coherus BioSciences G-CSF Injection Product Overview
- 9.6.3 Coherus BioSciences G-CSF Injection Product Market Performance
- 9.6.4 Coherus BioSciences Business Overview
- 9.6.5 Coherus BioSciences Recent Developments
- 9.7 Inc.
- 9.7.1 Inc. Basic Information
- 9.7.2 Inc. G-CSF Injection Product Overview
- 9.7.3 Inc. G-CSF Injection Product Market Performance
- 9.7.4 Inc. Business Overview
- 9.7.5 Inc. Recent Developments
- 9.8 Teva Pharmaceutical
- 9.8.1 Teva Pharmaceutical Basic Information
- 9.8.2 Teva Pharmaceutical G-CSF Injection Product Overview
- 9.8.3 Teva Pharmaceutical G-CSF Injection Product Market Performance
- 9.8.4 Teva Pharmaceutical Business Overview
- 9.8.5 Teva Pharmaceutical Recent Developments
- 9.9 Sanofi
- 9.9.1 Sanofi Basic Information
- 9.9.2 Sanofi G-CSF Injection Product Overview
- 9.9.3 Sanofi G-CSF Injection Product Market Performance
- 9.9.4 Sanofi Business Overview
- 9.9.5 Sanofi Recent Developments
- 9.10 Yifan Pharmaceutical
- 9.10.1 Yifan Pharmaceutical Basic Information
- 9.10.2 Yifan Pharmaceutical G-CSF Injection Product Overview
- 9.10.3 Yifan Pharmaceutical G-CSF Injection Product Market Performance
- 9.10.4 Yifan Pharmaceutical Business Overview
- 9.10.5 Yifan Pharmaceutical Recent Developments
- 9.11 CSPC
- 9.11.1 CSPC Basic Information
- 9.11.2 CSPC G-CSF Injection Product Overview
- 9.11.3 CSPC G-CSF Injection Product Market Performance
- 9.11.4 CSPC Business Overview
- 9.11.5 CSPC Recent Developments
- 9.12 Jiangsu Hengrui Medicine
- 9.12.1 Jiangsu Hengrui Medicine Basic Information
- 9.12.2 Jiangsu Hengrui Medicine G-CSF Injection Product Overview
- 9.12.3 Jiangsu Hengrui Medicine G-CSF Injection Product Market Performance
- 9.12.4 Jiangsu Hengrui Medicine Business Overview
- 9.12.5 Jiangsu Hengrui Medicine Recent Developments
- 9.13 Qilu Pharmaceutical
- 9.13.1 Qilu Pharmaceutical Basic Information
- 9.13.2 Qilu Pharmaceutical G-CSF Injection Product Overview
- 9.13.3 Qilu Pharmaceutical G-CSF Injection Product Market Performance
- 9.13.4 Qilu Pharmaceutical Business Overview
- 9.13.5 Qilu Pharmaceutical Recent Developments
- 9.14 Shan Dong Kexing Biopharm
- 9.14.1 Shan Dong Kexing Biopharm Basic Information
- 9.14.2 Shan Dong Kexing Biopharm G-CSF Injection Product Overview
- 9.14.3 Shan Dong Kexing Biopharm G-CSF Injection Product Market Performance
- 9.14.4 Shan Dong Kexing Biopharm Business Overview
- 9.14.5 Shan Dong Kexing Biopharm Recent Developments
- 10 G-CSF Injection Market Forecast by Region
- 10.1 Global G-CSF Injection Market Size Forecast
- 10.2 Global G-CSF Injection Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe G-CSF Injection Market Size Forecast by Country
- 10.2.3 Asia Pacific G-CSF Injection Market Size Forecast by Region
- 10.2.4 South America G-CSF Injection Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Sales of G-CSF Injection by Country
- 11 Forecast Market by Type and by Application (2026-2033)
- 11.1 Global G-CSF Injection Market Forecast by Type (2026-2033)
- 11.2 Global G-CSF Injection Market Forecast by Application (2026-2033)
- 12 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
